Pharmacology

A double-blind, placebo-controlled, crossover trial of sildenafil, brand name Viagra, showed improvement in echocardiogram measures of myocardial performance in children and young adults after Fontan surgery - basically, kids with congenital heart defects were helped by a drug commonly associated with sexual dysfunction in older men.

Fontan surgery, also called the Fontan/Kreutzer procedure, was developed in 1968 and first performed by Francis Fontan, where he connected the right atrium directly to the pulmonary artery, basically meaning he got a defective heart to work without the right ventricle, functioning with three chambers instead of four.
Researchers have presented clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, also helps people to quit smoking marijuana (cannabis). Unlike traditional addiction treatments, gabapentin targets stress systems in the brain that are activated by drug withdrawal.

In a 12-week trial of 50 treatment-seeking cannabis users, those who took gabapentin used less cannabis, experienced fewer withdrawal symptoms, like sleeplessness, and scored higher on tests of attention, impulse-control, and other cognitive skills, compared to patients who received a placebo. If these results are confirmed by ongoing larger trials, gabapentin could become the first FDA-approved pharmaceutical treatment for cannabis dependence.
A group of neuroscientists and ethicists have recently published a paper warning about the perils of the use of pharmacological drugs for cognitive enhancement by healthy individuals. The paper can be found here: http://www.tandfonline.com/doi/abs/10.1080/21507740.2012.663056 


A commentary about this paper and other related neuroscientific evidence can be found here: http://www.tandfonline.com/doi/abs/10.1080/21507740.2012.666322 



ONO-4641, an investigational oral drug, reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented this week at the American Academy of Neurology Meeting in New Orleans.

Evidence suggests that eating blueberries, blackberries, strawberries and other berry fruits has beneficial effects on the brain and may help prevent age-related memory loss and other changes, scientists report. 

In a new review, Barbara Shukitt-Hale, Ph.D., and Marshall G. Miller point out that longer lifespans are raising concerns about the human toll and health care costs of treating Alzheimer's disease and other forms of mental decline. 

They explain that recent research increasingly shows that eating berry fruits can benefit the aging brain. To analyze the strength of the evidence about berry fruits, they extensively reviewed cellular, animal and human studies on the topic.

What's the one thing that could make anti-science progressives dislike genetic modifications and medicine even more than they do now?  Putting them both together.
It may turn out that coffee is bad for you. The World Health Organization already lists it as a possible carcinogen, despite any evidence, but they do the same thing about cell phones, in contrast to any evidence - perhaps Big Tea donates a lot to WHO.

Until a group more scientifically valid than WHO finds a problem with coffee, Science 2.0 will continue to push articles extolling it - the bolder the better, like us.  Even decaffeinated coffee may be terrific. Researchers from Mount Sinai School of Medicine have discovered that decaffeinated coffee may improve brain energy metabolism associated with type 2 diabetes, a known risk factor for dementia and other neurodegenerative disorders like Alzheimer's disease. 
It's often the case that when something claims to cure everything, a little skepticism is warranted.  We have dozens of articles here on Resveratrol but over time the titles began to reflect growing disbelief it could be that perfect.  By the time it received gushing endorsements from Dr. Oz. and the other Four Horsemen of the Alternative (Gupta, etc.) we were crafting titles like Resveratrol - 2009's Miracle Compound Du Jour.

An international clinical trial shows that treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival. 

The findings in the New England Journal of Medicine report that the drug halted the cancer's return for two months overall but for women with the highest risk disease, the delay was five to six months and the findings also indicate a strong trend to improved overall survival, which is being analyzed until 2013. 

The seven-year study began in 2004 and enrolled 1,528 women with ovarian cancer at 263 centres, including 20 in Canada. Avastin was added to chemotherapy treatment and given intravenously every three weeks for 12 months.

A lot of research concerning alcoholism and other forms of substance abuse uses animal models. With respect to alcoholism, however, these animal models show one big difference with ‘real’ alcoholics: when given the choice, the animals (often mice) still prefer non-alcoholic drinks, such as water. So, unless alcohol is the only choice, or is administered by the experimenters, they are not really alcoholics.

Until now. A new study, published in Addiction Biology, reports the selective breeding of genuine mice alcoholics. Selectively bred for 40 generations by researchers from Indiana University – Purdue University Indianapolis, the mice lines are known as High Alcohol Preferring (or HAP) mice. The animals were specifically bred for their intake of 10% ethanol.